Chemistry-based design of inhibitors for carboxypeptidase A

Current Topics in Medicinal Chemistry

Volumn 4, Issue 12, 2004, Pages 1217-1226

  Kim, Dong H ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZIRIDINE DERIVATIVE; CARBOXYPEPTIDASE A; CARBOXYPEPTIDASE A INHIBITOR; ENZYME INHIBITOR; ETHYLENE OXIDE DERIVATIVE; FUNCTIONAL GROUP; ISOXAZOLINE DERIVATIVE; METALLOPROTEINASE; N (3 CHLOROPROPIONYL)PHENYLALANINE; N (BROMOACETYL) N METHYLPHENYLALANINE; N (HYDROXYACETYL)PHENYLALANINE; OXAZOLIDINONE DERIVATIVE; PHENYLALANINE METHYL ESTER; UNCLASSIFIED DRUG; ZINC ION;

DRUG DESIGN; DRUG SELECTIVITY; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; MOLECULAR MODEL; MOLECULAR SIZE; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 85041118463     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043387908     Document Type: Review

References (46)

1. Lipscomb, N. W.; Sträter, N. Recent Advances in Zinc Enzymology. Chem. Rev. 1996, 96, 2375 - 2433.
2. Ondetti, M. A.; Rubin, B.; Cushman, D. W. Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents. Science 1977, 196, 441 - 444.
3. Whittaker, M.; Floyd, C. D.; Brown, P.; Gearing, A. J. H. Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors. Chem. Rev. 1999, 99, 2735 - 2776.
4. Christianson, D., W.; Lipscomb, N. W. Carboxypeptidase A. Acc. Chem. Res. 1989, 22, 62 - 69.
5. Rees, D. C.; Lewis, M.; Lipscomb, W. N. Refined Crystal Structure of Carboxypeptidase A at 1.54 Å Resolution. J. Mol. Biol. 1983, 168, 367 - 387.
6. Christianson, D., W.; Lipscomb, N. W. X-ray crystallographic investigation of substrate binding to carboxypeptidase A at subzero temperature. Proc. Natl. Acad. Sci. USA. 1986, 83, 7586 - 7577.
7. Christianson, D., W.; Lipscomb, N. W. The complex between carboxypeptidase A and a possible transition-state analogue: Mechanistic inferences from high resolution X-ray structures of enzyme-inhibitor complex. J. Am. Chem.. Soc. 1986, 108, 4998 - 5003.
8. Christianson, D., W.; Lipscomb, N. W. Carboxypeptidase A: Novel enzyme-substrate-product complex. J. Am. Chem.. Soc. 1987, 109, 5536 - 5538.
9. Phillips, M. A.; Fletterick, R.; Rutter, W. J. Arginine 127 stabilizes the transition state in carboxypeptidase A. J. Biol. Chem. 1990, 265, 20692 - 20698.
10. Auld, D. S.; Galdes, A.; Geoghegan, K. F.; Holmquist, B.; Martinelli, R. A.; Vallee, B. L. Cryospectrokinetic characterization of intermediates in biochemical reactions: Carboxypeptiesase A. Proc. Natl. Acad. Sci. USA 1984, 81, 5041 - 5045.
11. Breslow, R.; Wernick, D. L. Unified picture of mechanisms of catalysis by carbopeptidase A. Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 1303 - 1307.
12. Lee, M.; Kim, D. H. Hippuryl-α-methyphenylalanine and hippuryl-α-methyphenyllactic acid as substrates for carboxypeptidase A. Syntheses, kinetic evaluation and mechanistic implication. Bioorg. Med. Chem. 2000, 8, 815 - 823.
13. Makinen, M. W.; Yamamura, K.; Kaiser, E. T. Mechanism of action of carboxypeptidase A in ester hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 1976, 76, 3882 - 3886.
14. Sander, M. E.; Witzel, H. Direct chemical evidence for the mixed anhydride intermediate of carboxypeptidase A in ester and peptide hydrolysis. Biochem. Biophys. Res. Commun. 1985. 132, 681 - 687.
15. Lee, M. J.; Kim, D. H. Hippuryl-α-methylphenylalanine and hippuryl-α-methylphenyllactic acid as substrates for carboxypeptidase A. Syntheses, kinetic evaluation and mechanistic implication. Bioorg. Med. Chem. 2000, 8, 815 - 823.
16. Auld, D. S.; Holmquist, B. Carboxypeptidase A. Differences in the Mechanisms of Ester and Peptide Hydrolysis. Biochemistry 1974, 13, 4355 - 4361.
17. Galdes, A.; Auld, D. S.; Vallee, B. L. Cryokinetic Studies of the Intermediates in the Mechanism of Carboxypeptidase A. Biochemistry 1983, 22, 1888 - 1893.
18. Galdes, A.; Auld, D. S.; Vallee, B. L. Elucidation of the chemical nature of the steady-state intermediates in the mechanism of carboxypeptidase A. Biochemistry 1986, 25, 646 - 651.
19. Powers, J. C.; Harper, J. W. Inhibitors of Metalloproteases. In Protainase Inhibitors; Barrett, A. J.; Salvesen, G.; Eds.; Elsevier: New York, 1986; pp 219 -298.
20. Leu by N-bromoacetyl-N-methyl-L-phenyalanine. I. Kinetics of Inactivation. Biochemistry 1971, 10, 3535 - 3540.
21. Leu by N-bromoacetyl-N-methyl-L-phenyalanine. II. Biochemistry 1971, 10, 3541 - 3546.
22. Sugimoto, T.; Kaiser, E. T. Carboxypeptidase A catalyzed enolization of a ketonic substrate. A new stereochemical probe for an enzyme-bound nucleophile. J. Am. Chem. Soc. 1978, 100, 7750-7751.
23. Sugimoto, T.; Kaiser, E. T. Elucidation of the stereochemistry of the carboxypeptidase A catalyzed enolization of 2-benzyl-3-p-methoxybenzylpropionate, a ketone substrate. J. Am. Chem. Soc. 1979, 101, 3946 - 3951.
24. Mobashery, S.; Ghosh, S. S.; Tamura, S. Y.; Kaiser, E. T. Design of an Effective Mechanism-based Inactivator for a Zinc Protease. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 578 - 582.
25. Ghosh, S. S.; Wu, Y.-Q.; Mobashery, S. Peptide Mechanism-based Inactivators for Carboxypeptidase A. J. Biol. Chem. 1991, 266, 8759 - 8764.
26. Ghosh, S. S.; Dakoji, S.; Tanake, Y.; Cho, Y. J.; Mobashery, S. Properties of analogues of an intermediate in the process of mechanism-based inactivation of carboxypeptidase A. Bioorg. Med. Chem. 1996, 4, 1487 - 1492.
27. Ner, S. K.; Suckling, C. J.; Bell, A. R.; Wrigglesworth, R. Inhibition of Carboxypeptidase A by Cyclopropane-containing Peptides. J. Chem. Soc. Chem. Commun. 1987, 480 - 482.
28. Kemp, A.; Ner, S. K.; Rees, L.; Suckling, C. J.; Tedford, M. C.; Bell, A. R.; Wrigglesworth, R. Latent Inibitors. Part 9. Substrate Activated Time-dependent Inhibition of Carboxypeptidase A by Aminocyclopropanecarboxylic Acid Derivatives and Analogues. J. Chem. Soc. Chem. Perkin Trans 2, 1993, 741 - 748.
29. Kemp, A.; Tedford, M. C.; Suckling, C. J. Substrate Activated Time Dependent Inhibition of Carboxypeptidase A by Aminocyclopropane Carboxylic Acid Derivatives and Analogues. Bioorg. Med. Chem. Lett. 1991, 1, 557 - 562.
30. Kim, D. H.; Kim, K. B. Design of a novel type of zinc-containing proteases inhibitor. J. Am. Chem. Soc. 1991, 113, 3200 - 3202.
31. Yun, M.; Park, C.; Kim, S.; Nam, D.; Kim, S. C.; Kim, D. H. X-ray crystallographic study of covalently modified carboxypeptidase A by a 2-benzyl-3,4-epoxybutanoic acid, a pseudomechanism-based inactivator. J. Am. Chem. Soc. 1992, 114, 2281 - 2282.
32. Lee, S. S.; Li, Z.-H.; Lee, D. H.; Kim, D. H. (2R,3S)- and (2S,3R)-2-Benzyl-3,4-epoxybutanoic acid as highly efficient and last acting pseudomechanism-based inactivators for carboxypeptidase A: Design, asymmetric synthesis and inhibitory kinetics. J. Chem. Soc. Perkin Trans. 1 1995, 2877 - 2882.
33. Ryu, S.-E.; Choi, H.-J.; Kim, D. H. Stereochemistry in inactivation of carboxypeptidase A. Structural analysis of the inactivated carboxypeptidase A by an enantiomeric pair of 2-benzyl-3,4-epoxybutanoic acids. J. Am. Chem. Soc. 1997, 119, 38 - 41.
34. Kim, D. H.; Chung, S. J. Inactivation of carboxypeptidase A by 2-benzyl-3,4-epithobutanoic acid. Bioorg. Med. Chem. Lett. 1995, 5, 1667 - 1672.
35. Park, J.; Kim, D. H. 2-Benzyl-3,4-iminobutanoic acid as inhibitor of carboxypeptidase A. Bioorg. Med. Chem. Lett. 2001, 11, 2967 - 2970.
36. Lee, K. J.; Kim, D. H. Inactivation of a prototypic zinc-containing protease with (S)-2-benzyl-2-(3-oxo-2-isoxazolidinyl)acetic acid. Bioorg. Med. Chem. Lett. 1996, 6, 2431 - 2436.
37. Tanaka, Y,; Crapsas, I.; Dakoji, S.; Cho, Y. J.; Mobashery, S. Conscripting the Active-site Zinc Ion in Carboxypeptidase A in Inactivation Chemistry by a New Type of Irreversible Enzyme Inactivator. J. Am. Chem. Soc. 1994, 116, 7485 - 7480.
38. Massova, I.; Martin, P.; de Mel, S.; Tanake, Y.; Edwards, B.; Mobashery, S. Crystallographic and Computational Insight on the Mechanism of Zinc-Ion-Dependent Inactivation of Carboxypeptidsae A by 2-Benzyl-3-iodopropanoate. J. Am. Chem. Soc. 1996, 118, 12479 - 12480.
39. Izmiya, N.; Uchino, H. Action of carboxpeptidase on synthetic substrates. I. Action f carboxpeptidase on mono- di-, tri-, tetra-, and pentaglycyl-L-tyrosines. J. Biochem. 1959, 46, 235 - 245.
40. Lee, K. J.; Kim, D. H. Design of mechanism-based carboxy-A inactivators on the basis of the X-ray crystal structure and catalytic reaction mechanism. Bioorg. Med. Chem. 1998, 6, 1613 - 1622.
41. Nemirowsky, J. J. J. Prakt. Chem. 1885, 31, 175.
42. Chung, S. J.; Chung, S.; Lee, H. S.; Kim, E.-J.; Oh, K. S.; Choi, C. H.; Kim, K. S.; Kim, Y. J.; Hahn, J. H.; Kim. D. H. Mechanistic insight into the inactivation of carboxypeptidase A by α-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity. J. Org. Chem. 2001, 66, 6462 - 6471.
43. Storm, D. R.; Koshland, Jr. D. E. Effect of small changes in orientation on reaction rate. J. Am. Chem. Soc. 1972, 94, 5815-5825.
44. 4-tetrahydrophthalate Monophenyl Esters. J. Am. Chem. Soc. 1996, 118, 2595-2605.
45. Fife, T. H. General Acid Catalysis of Acetal, Ketal, and Ortho Ester Hydrolysis. Acc. Chem. Res. 1972, 5, 264 - 272.
46. Han, M. S.; Ryu, C. H.; Chung, S. J.; Kim, D. H. A novel strategy for designing irreversible inhibitors of metalloproteases: Acetals as latent electrophiles that interact with catalytic nucleophile at the active site. Org. Lett. 2000, 2. 3149 - 3152.